CanaQuest Medical Corp. (CANQF) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

CanaQuest Medical Corp.

CANQF

OTC

Unprofitable

EPS improving

Unprofitable

EPS improving

388625

Drug Manufacturers - Specialty & Generic

0.02USD

0.01 ( 60.83%)

Pre-market 0.02$

0.00 (0.00%)

Market Open

Relative Strenght

Volume Buzz

-86%

Earning Acce

Yes

Dist 52w H.

79%

Overview Chart

Quote Panel

Updated June 18, 2025

1W 60.83 % 1M 60.83 % 3M -3.50 % 1Y -75.84 %

Key Metrics

Market Cap
388625
Shares Outstanding
20.14M
Share in Float
8.49M
Dividende
0

Earning Date
No Data
Price Target
0.0193
Average Volume
2296
Beta
0.877

Range
0.0102-0.0899
Industry
Drug Manufacturers - Specialty & Generic
Website
https://canaquest.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

7.95x

P/S Ratio

-0.51x

P/B Ratio

-0.1

Debt/Equity

-3034.1%

Net Margin

$-0.0

EPS

How CANQF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

CANQF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

-0.00
vs NA

Q4.22

N/A

-0.02
vs NA

Q1.23

N/A

-0.00
vs NA

Q2.23

N/A

-0.00
vs -0.00

Q3.23

N/A

-0.00
vs -0.00

Q4.23

N/A

-0.02
vs -0.02

Q1.24

N/A

-0.02
vs -0.00

Q2.24

N/A

-0.01
vs -0.00

Q3.24

N/A

-0.01
vs -0.00

Q4.24

N/A

-0.00
vs -0.02

Sales Growth

YoY

Current

Estimates

Q3.22

NA vs NA

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

8.3K vs NA

Q4.23

12.4K vs NA

Q1.24

13.2K vs NA

Q2.24

13.2K vs NA

Q3.24

+57%

13K vs 8.3K

Q4.24

-24%

9.4K vs 12.4K

Return on Equity

QoQ

Q1.23

+12%

0.12
vs 0.51

Q2.23

+11%

0.11
vs 0.12

Q3.23

+8%

0.08
vs 0.11

Q4.23

+57%

0.57
vs 0.08

Q1.24

+63%

0.63
vs 0.57

Q2.24

+28%

0.28
vs 0.63

Q3.24

+26%

0.26
vs 0.28

Q4.24

+18%

0.18
vs 0.26

Institutionnal Ownership

Earnings Growth

Latest News

accesswire.com

8 hours ago

CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health

accesswire.com

8 hours ago

CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications

accesswire.com

9 hours ago

CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

Company Description

0.02USD

N/A

7.95x

-0.51x

-0.1

-3034.1%

$-0.0

Earnings Growth

Latest News

N/A

7.95x

-0.51x

-0.1

-3034.1%

$-0.0